Arunava Roy

Tata Medical Center, Women's Health Initiative

Papers

2

Total Citations

4

H-Index

1

About

Dr. Arunava Roy is a leading Indian gynecologic oncologist whose research is reshaping the surgical management of endometrial cancer. His work centers on two critical, interrelated areas: validating sentinel lymph node (SLN) biopsy as a less invasive alternative to full lymphadenectomy, and rigorously comparing the outcomes of open, laparoscopic, and robotic-assisted surgical approaches. Dr. Roy’s major contribution lies in providing high-quality, real-world evidence from the Indian context, where such data were previously scarce. His landmark 2023 study, cited 3 times, validated the accuracy of SLN biopsy in robotic staging at a high-volume center, demonstrating its potential to reduce surgical morbidity without compromising oncologic safety. Building on this, his 2025 multicenter study for the Indian Gynecologic-Onco Study Group offers crucial insights into the comparative perioperative and short-term outcomes of open, laparoscopic, and robotic surgery for stage I disease. By generating this foundational evidence, Dr. Roy is directly informing surgical decision-making and helping to advance minimally invasive, patient-centered care for endometrial cancer in India and beyond.

Research Focus

Key Achievements

1
H-Index
2
Papers
4
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Validation of Sentinel Lymph Node Biopsy in Robotic Endometrial Cancer Staging Surgery: Results From a High-Volume Center in India
3 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 23
🏛 Institutions: Tata Medical Center, Women's Health Initiative

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago